Results 341 to 350 of about 226,665 (388)
Some of the next articles are maybe not open access.
Rheumatic Disease Clinics of North America, 2005
Sex hormones seem to play an important role as modulators and perpetuators of rheumatic disorders with autoimmune involvement, such as rheumatoid arthritis or systemic lupus erythematosus. Estrogens are implicated in the immune response as enhancers of the humoral immunity.
Robert G. Lahita+2 more
openaire +4 more sources
Sex hormones seem to play an important role as modulators and perpetuators of rheumatic disorders with autoimmune involvement, such as rheumatoid arthritis or systemic lupus erythematosus. Estrogens are implicated in the immune response as enhancers of the humoral immunity.
Robert G. Lahita+2 more
openaire +4 more sources
AWHONN Lifelines, 2001
“I have some bad news and some good news for you,” the gynecologist said, face grim, eyes kind, as he intently looked at me.
openaire +3 more sources
“I have some bad news and some good news for you,” the gynecologist said, face grim, eyes kind, as he intently looked at me.
openaire +3 more sources
Estrogen or estrogen receptor?
Trends in Endocrinology & Metabolism, 2003View Large Image | Download PowerPoint SlideAs a clinical breast oncologist, I was eager to review Endocrine Therapy in Breast Cancer. Hormonal manipulation has been the predominant form of breast cancer treatment for >50 years. Surgical ablation, high-dose estrogens, LHRH agonists and antiestrogens have all shown clinical benefit.
openaire +2 more sources
Enzymatic treatment of estrogens and estrogen glucuronide
Journal of Environmental Sciences, 2009Natural and synthetic estrogens from sewage treatment systems are suspected to influence the reproductive health of the animals in the rivers. In this article, we investigated the enzymatic treatment of three estrogens (estrone, 17beta-estradiol, and 17alpha-ethynyletstradiol) by a fungal laccase which oxidize phenolic compounds with dissolved oxygen ...
Tomokazu Kawase+6 more
openaire +3 more sources
International Journal of Gynecology & Obstetrics, 1990
The main types of pharmacologic therapy used to treat the hormone deficiency of menopause are parenteral and oral administrations of estrogen. Parenteral administration results in predictable absorption without major intermediary metabolism, whereas all oral estrogens are subject to intestinal metabolism before entering the systemic circulation ...
openaire +2 more sources
The main types of pharmacologic therapy used to treat the hormone deficiency of menopause are parenteral and oral administrations of estrogen. Parenteral administration results in predictable absorption without major intermediary metabolism, whereas all oral estrogens are subject to intestinal metabolism before entering the systemic circulation ...
openaire +2 more sources
Biological Role of Estrogen and Estrogen Receptors
Critical Reviews in Biochemistry and Molecular Biology, 2002(2002). Biological Role of Estrogen and Estrogen Receptors. Critical Reviews in Biochemistry and Molecular Biology: Vol. 37, No. 1, pp. 1-28.
Jan-Åke Gustafsson, Stefan Nilsson
openaire +3 more sources
Estrogen and estrogen receptors of breast cancer
Journal of Surgical Oncology, 1975AbstractHuman breast cancer can be divided into a group that contains specific receptor sites for estrogen and a group without such specific estrogen‐binding sites. The presence of specific estrogen receptors in some tumors indicating hormonal dependency has been shown to be of predictive value for endocrine treatment.
Howard H. Sky-Peck+3 more
openaire +3 more sources
JAMA: The Journal of the American Medical Association, 1976
RECENT reports suggest that the administration of estrogens to postmenopausal women is associated with an increased risk of acquiring endometrial cancer. The problem was identified in retrospective studies in which postmenopausal patients with endometrial cancer were compared to matched controls with respect to their history of estrogen therapy.
openaire +4 more sources
RECENT reports suggest that the administration of estrogens to postmenopausal women is associated with an increased risk of acquiring endometrial cancer. The problem was identified in retrospective studies in which postmenopausal patients with endometrial cancer were compared to matched controls with respect to their history of estrogen therapy.
openaire +4 more sources
Science, 1998
Robert Service's article “New role for estrogens in cancer?” (Research News, 13 Mar., [p. 1631][1]) reminds us of the dark side of estrogen metabolites in promoting cancers. However, a major estrogen metabolite, 2-methoxyestradiol (2ME2), represents the bright side of the story.
Shawn J. Green, Victor S. Pribluda
openaire +3 more sources
Robert Service's article “New role for estrogens in cancer?” (Research News, 13 Mar., [p. 1631][1]) reminds us of the dark side of estrogen metabolites in promoting cancers. However, a major estrogen metabolite, 2-methoxyestradiol (2ME2), represents the bright side of the story.
Shawn J. Green, Victor S. Pribluda
openaire +3 more sources
Estrogen Receptors and Anti-Estrogen Therapies
2006The realisation that breast cancer growth is regulated by the hormone estrogen led to the development of tamoxifen as the first target-directed cancer drug. Clearly, there is considerable headway to be made in further elucidating estrogen receptor function, in particular in identifying the mechanisms underlying endocrine resistance.
Simak Ali+3 more
openaire +3 more sources